Real-time Estimate
Cboe BZX
03:07:20 2024-05-28 pm EDT
|
5-day change
|
1st Jan Change
|
11.24
USD
|
-2.05%
|
|
-5.03%
|
-47.87%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
6,060
|
28,986
|
14,699
|
3,830
|
3,568
|
1,947
|
-
|
-
|
Enterprise Value (EV)
1 |
5,986
|
29,622
|
15,051
|
4,466
|
4,026
|
2,244
|
2,008
|
1,773
|
P/E ratio
|
-60.7
x
|
-37.3
x
|
-33.6
x
|
-0.28
x
|
-16.1
x
|
-10.7
x
|
-17.1
x
|
-21.9
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
11
x
|
26.5
x
|
7.23
x
|
1.59
x
|
1.37
x
|
0.73
x
|
0.71
x
|
0.68
x
|
EV / Revenue
|
10.8
x
|
27.1
x
|
7.4
x
|
1.86
x
|
1.55
x
|
0.84
x
|
0.73
x
|
0.62
x
|
EV / EBITDA
|
188
x
|
234
x
|
56.2
x
|
18.1
x
|
12.3
x
|
6.14
x
|
4.83
x
|
3.98
x
|
EV / FCF
|
316
x
|
-372
x
|
79.2
x
|
25.8
x
|
30.9
x
|
10.9
x
|
7.15
x
|
5.47
x
|
FCF Yield
|
0.32%
|
-0.27%
|
1.26%
|
3.87%
|
3.23%
|
9.16%
|
14%
|
18.3%
|
Price to Book
|
6.01
x
|
1.14
x
|
0.9
x
|
1.65
x
|
1.52
x
|
0.84
x
|
0.85
x
|
0.85
x
|
Nbr of stocks (in thousands)
|
72,382
|
144,961
|
160,087
|
161,927
|
165,557
|
169,588
|
-
|
-
|
Reference price
2 |
83.72
|
200.0
|
91.82
|
23.65
|
21.55
|
11.48
|
11.48
|
11.48
|
Announcement Date
|
2/26/20
|
2/24/21
|
2/22/22
|
2/22/23
|
2/20/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
553.3
|
1,094
|
2,033
|
2,407
|
2,602
|
2,660
|
2,755
|
2,868
|
EBITDA
1 |
31.83
|
126.8
|
267.8
|
246.5
|
328.1
|
365.2
|
416
|
445.3
|
EBIT
1 |
-80.44
|
-506.4
|
-265.6
|
-13,653
|
-248.6
|
-215.5
|
-132.8
|
-40.57
|
Operating Margin
|
-14.54%
|
-46.29%
|
-13.07%
|
-567.27%
|
-9.55%
|
-8.1%
|
-4.82%
|
-1.41%
|
Earnings before Tax (EBT)
1 |
-109.5
|
-576
|
-384.7
|
-13,663
|
-219.6
|
-179.9
|
-119.2
|
-58.81
|
Net income
1 |
-98.86
|
-485.1
|
-428.8
|
-13,660
|
-220.4
|
-177.1
|
-110.3
|
-82.71
|
Net margin
|
-17.87%
|
-44.35%
|
-21.09%
|
-567.53%
|
-8.47%
|
-6.66%
|
-4%
|
-2.88%
|
EPS
2 |
-1.380
|
-5.360
|
-2.730
|
-84.60
|
-1.340
|
-1.069
|
-0.6725
|
-0.5254
|
Free Cash Flow
1 |
18.97
|
-79.55
|
189.9
|
172.8
|
130.1
|
205.6
|
280.7
|
324
|
FCF margin
|
3.43%
|
-7.27%
|
9.34%
|
7.18%
|
5%
|
7.73%
|
10.19%
|
11.3%
|
FCF Conversion (EBITDA)
|
59.59%
|
-
|
70.92%
|
70.1%
|
39.64%
|
56.28%
|
67.46%
|
72.77%
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/26/20
|
2/24/21
|
2/22/22
|
2/22/23
|
2/20/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
554.2
|
565.4
|
592.4
|
611.4
|
637.7
|
629.2
|
652.4
|
660.2
|
660.5
|
646.1
|
650.8
|
674
|
687.8
|
675.3
|
680.6
|
EBITDA
1 |
77.08
|
54.5
|
46.71
|
51.21
|
94.09
|
52.76
|
72.16
|
88.76
|
114.4
|
63.14
|
75.01
|
98.36
|
129.6
|
80.61
|
92.46
|
EBIT
1 |
-41.43
|
-6,669
|
-3,097
|
-71.73
|
-3,816
|
-77.1
|
-71.64
|
-64.72
|
-35.08
|
-87.12
|
-68.49
|
-46.26
|
-13.73
|
-60.69
|
-41.85
|
Operating Margin
|
-7.47%
|
-1,179.69%
|
-522.73%
|
-11.73%
|
-598.32%
|
-12.25%
|
-10.98%
|
-9.8%
|
-5.31%
|
-13.48%
|
-10.52%
|
-6.86%
|
-2%
|
-8.99%
|
-6.15%
|
Earnings before Tax (EBT)
1 |
-60.73
|
-6,674
|
-3,103
|
-74.65
|
-3,812
|
-68.55
|
-66.13
|
-59.56
|
-25.38
|
-79.2
|
-61.48
|
-35.34
|
-4.561
|
-52.66
|
-39.97
|
Net income
1 |
-10.98
|
-6,675
|
-3,101
|
-73.48
|
-3,810
|
-69.23
|
-65.18
|
-57.07
|
-28.89
|
-81.89
|
-58.09
|
-33.79
|
-3.309
|
-51.67
|
-35.81
|
Net margin
|
-1.98%
|
-1,180.6%
|
-523.56%
|
-12.02%
|
-597.46%
|
-11%
|
-9.99%
|
-8.64%
|
-4.37%
|
-12.67%
|
-8.93%
|
-5.01%
|
-0.48%
|
-7.65%
|
-5.26%
|
EPS
2 |
-0.0700
|
-41.58
|
-19.22
|
-0.4500
|
-23.49
|
-0.4200
|
-0.4000
|
-0.3500
|
-0.1700
|
-0.4900
|
-0.3480
|
-0.2074
|
-0.0214
|
-0.2967
|
-0.2106
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/22/22
|
4/27/22
|
7/27/22
|
10/26/22
|
2/22/23
|
4/26/23
|
7/25/23
|
10/24/23
|
2/20/24
|
4/25/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
636
|
352
|
637
|
458
|
297
|
61.2
|
-
|
Net Cash position
1 |
73.9
|
-
|
-
|
-
|
-
|
-
|
-
|
173
|
Leverage (Debt/EBITDA)
|
-
|
5.011
x
|
1.315
x
|
2.582
x
|
1.395
x
|
0.8137
x
|
0.147
x
|
-
|
Free Cash Flow
1 |
19
|
-79.6
|
190
|
173
|
130
|
206
|
281
|
324
|
ROE (net income / shareholders' equity)
|
-9.75%
|
-5.74%
|
-2.69%
|
-149%
|
-9.51%
|
-6.51%
|
-5.6%
|
-5.09%
|
ROA (Net income/ Total Assets)
|
-6.31%
|
-5.01%
|
-2.42%
|
-2.15%
|
-5.04%
|
-3.74%
|
-2.79%
|
-2.02%
|
Assets
1 |
1,566
|
9,679
|
17,745
|
635,150
|
4,369
|
4,732
|
3,958
|
4,098
|
Book Value Per Share
2 |
13.90
|
175.0
|
102.0
|
14.30
|
14.10
|
13.60
|
13.50
|
13.50
|
Cash Flow per Share
2 |
0.4200
|
-0.5900
|
1.240
|
1.210
|
2.130
|
2.070
|
2.340
|
2.680
|
Capex
1 |
10.9
|
26
|
63.9
|
173
|
156
|
143
|
147
|
155
|
Capex / Sales
|
1.97%
|
2.38%
|
3.15%
|
7.18%
|
6.01%
|
5.38%
|
5.33%
|
5.41%
|
Announcement Date
|
2/26/20
|
2/24/21
|
2/22/22
|
2/22/23
|
2/20/24
|
-
|
-
|
-
|
Last Close Price
11.48
USD Average target price
16.95
USD Spread / Average Target +47.67% Consensus |
1st Jan change
|
Capi.
|
---|
| -47.87% | 1.95B | | +78.57% | 584M | | +11.02% | 485M | | -71.18% | 128M | | -28.06% | 91.48M |
Telemedicine Services
|